Why is it so hard to engage in mobile health?
August 26, 2019

Why is it so hard to engage in mobile health?

We all know that there is an established need for health Apps with over 70% of people taking a prescribed medicine at any time (Talking Medicines 2017), health is an everyday problem for you & I. If you turn on the radio, read the daily newspaper or watch TV then you see that health is topical, its part of our conversation. We know more and more people want to take control of their own health & empowerment of the patient is a running theme for the industry. Healthcare consumers show good uptake of digital technology, 75% of consumers surveyed said technology is important in managing health (Accenture). Creators of mobile Apps have responded & fuelled a plethora of health Apps in the market place. It is estimated that there are 318,000 health Apps globally with 200 being added everyday (IQVIA). The mhealth market is projected to reach US$102 Bn by 2023 (Liquid State 2018). This is fuelled as adoption of smartphones across age groups becomes ubiquitous and with heavy investment in digital health from the start up and venture capital community.

So demand & supply are strong, is it easy to succeed?

The answer is no, only 4% of mHealth app publishers achieve more than 1 Million downloads annually, and only 15% achieve 50,000 to 250,000 downloads annually (Research2Guidance). Medsmart® has been designed by Talking Medicines to help patients manage their own medicines at home and is unusual in that it is a unified solution covering all of the medicines of a user rather than just those for just one company or disease area. Medsmart® has reached that top 15% bracket & Talking Medicines have learnt what makes an App solution appeal or fail:

Questions to ask for a winning solution

Is it addressing a problem? It will not win if it fails to solve a problem – users are vulnerable & looking for answers, if the solution doesn’t immediately help them they will abandon and uninstall.

Is the user genuinely at the centre of the experience? An App is not as an extension of a website, it needs its own user experience development and testing. If its not intuitive then its won’t gain engagement.

How is the user addressed? Addressing the user as a consumer not just as a patient, recognising they have choices and consumer psyche. An App is a relationship tool & the consumer has a life around them.

Can it help empower? Giving consumers tools that will help them manage their own health, wellness or disease condition has utility for repeated usage.

The market is an exciting one, dynamic and no solution stands still as consumers become more demanding and technology continues to enhance how the relationship can be developed. It may not get any easier to succeed but for those that do there are rich rewards in knowing that consumers can be supported in their health and wellbeing through mhealth.

Source: https://liquid-state.com/mhealth-apps-market-snapshot/

Recent Blogs

Softening of public attitude towards COVID-19 vaccines

Softening of public attitude towards COVID-19 vaccines

In December Talking Medicines carried out two ‘pulse’ surveys of the UK public to gauge opinion towards COVID-19 vaccines and found that over the month, attitude had softened, with more people intending to take the vaccine once it becomes available to them. The...

Growing the Product Tech Team

Growing the Product Tech Team

We are so pleased to welcome four talented individuals to our team. Through their knowledge and experience, we look forward to accelerating our AI driven data insights product aligned to the needs of our commercial marketing pharmaceutical customers. Stewart McKee -...

AstraZeneca and Oxford University gain approval on new COVID-19 vaccine

AstraZeneca and Oxford University gain approval on new COVID-19 vaccine

The UK has now approved its second vaccine for COVID-19. Last week, AstraZeneca (Pharmaceutical company) and Oxford University’s vaccine was approved for use and has since been administered to the public. From this week there will be half a million doses available for...